Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
5.69
-0.11 (-1.90%)
At close: Oct 03, 2025, 3:59 PM
5.78
1.58%
After-hours: Oct 03, 2025, 05:54 PM EDT
-1.90% (1D)
| Bid | 5.6 |
| Market Cap | 18.16M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -29.07M |
| EPS (ttm) | -24.28 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | -0.64 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 5.92 |
| Volume | 52,787 |
| Avg. Volume (20D) | 116,509 |
| Open | 5.85 |
| Previous Close | 5.80 |
| Day's Range | 5.65 - 5.90 |
| 52-Week Range | 4.11 - 67.50 |
| Beta | 0.59 |
| Ex-Dividend Date | n/a |
About CLRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLRB
Website n/a
3 months ago
-31.65%
Cellectar Biosciences shares are trading lower aft...
Unlock content with
Pro Subscription
3 months ago
+16.58%
Cellectar Biosciences shares are trading higher after the company announced initial results from the CLOVER-2 Phase 1 clinical trial evaluating iopofosine I 131 in relapsed/refractory pediatric high-grade glioma patients.
